A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score

Allergy and Asthma Proceedings

Volumn 31, Issue 1, 2010, Pages 5-9

  Sardana, Niti ^a   Santos, Carah ^a   Lehman, Erik ^b   Craig, Timothy ^b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Allergic rhinitis; Antihistamines; Azelastine; Budesonide; Intranasal corticosteroids; Leukotriene receptor antagonists; Montelukas

Indexed keywords

AZELASTINE; BUDESONIDE; MONTELUKAST; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; NOSE CAVITY; OCULAR PRURITUS; PALATE; PALLIATIVE THERAPY; PERENNIAL RHINITIS; PRURITUS; RHINITIS SEVERITY SCORE; RHINORRHEA; SCORING SYSTEM; SYMPTOM; THERAPY EFFECT; THROAT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACETATES; ADMINISTRATION, INTRANASAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BUDESONIDE; DOUBLE-BLIND METHOD; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; LEUKOTRIENE ANTAGONISTS; MIDDLE AGED; PHTHALAZINES; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RHINITIS, ALLERGIC, PERENNIAL; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76149111141     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2010.31.3308     Document Type: Article

References (16)

1. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99:S763-S772, 1997.
2. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101:633-637, 1998.
3. Vonesh EF, and Chinchilli VM. Linear and Nonlinear Models for the Analysis of Repeated Measurements. New York: Marcel Dekker, Inc., 160-165, 1997.
4. Berlin JM, Golden SJ, Teets S, et al. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc 100: S8-S13, 2000.
5. Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 47:118-125, 1998.
6. Storms W, Bronsky E, Findlay S, et al. Once daily triamcinolone acetonide nasal spray is effective for treatment of perennial allergic rhinitis. Ann Allergy 66:329-334, 1991.
7. Santos C, Pratt E, Hank C, et al. The effect of intranasal corticosteroids in treatment of allergic rhinitis and improvement of sleep, reduced daytime somnolence, and improved quality of life. Ann Allergy Asthma Immunol 97:579-586, 2006.
8. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101:633-637, 1998.
9. Golden D, Lehman EB, Chinchilli VM, and Craig TJ. The effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime fatigue in perennial allergic rhinitis. J Allergy Clin Immunol 103:S252, 1999 (Abs 967).
10. Ratner PH, Findlay SR, Hampel F Jr, et al. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergy rhinitis. J Allergy Clin Immunol 94:818-825, 1994.
11. Gastpar H, Dorow P, Aurich R, and Petzold U. Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis. Arzneimittelforschung 43:771-776, 1993.
12. Craig TJ, Hanks CD, and Fisher LH. How do topical nasal corticosteroids improve sleep and daytime somnolence in allergic rhinitis. J Allergy Clin Immunol 116:1264-1266, 2005.
13. Gurevich F, Glass C, Hughes K, et al. The effect of intranasal steroid budesonide on the congestion related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc 26:268-274, 2005.
14. Craig TJ, McCann JL, Gurevich F, and Davies MJ. The correlation between allergic rhinitis and sleep disturbances. J Allergy Clin Immunol 114:S139-S144, 2004.
15. Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58: 380-385, 2003.
16. Stempel DA, and Thomas M. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines. Am J Manag Care 4:89-96, 1998.